InvestorsHub Logo
Followers 186
Posts 3203
Boards Moderated 0
Alias Born 04/05/2006

Re: None

Friday, 07/10/2020 2:54:08 PM

Friday, July 10, 2020 2:54:08 PM

Post# of 834
Oragenics Provides Update on SARS-CoV-2 (COVID-19) Program
Business Wire Business Wire•July 10, 2020



While working with Aragen Bioscience, a leading contract research organization focused on accelerating preclinical biologics product development, to advance the Company’s recently acquired COVID-19 vaccine candidate, TerraCoV2, the National Institutes of Health-created stabilized pre-fusion spike protein gene has been successfully inserted into Chinese Hamster Cells ("CHO") and "mini-pool" production and analytical development are underway. The transfer to full-scale manufacture is expected to commence later this summer.

https://finance.yahoo.com/news/oragenics-provides-sars-cov-2-113000940.html


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent OGEN News